Article Text
Review
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies
Abstract
Gene therapy has emerged as a powerful and very plastic tool to regulate biological functions in diseased tissues with application in virtually all medical fields. An increasing number of experimental and clinical studies underline the importance of genes as curative agents in the future. However, intense research is needed to evaluate the potential of gene therapy to improve efficacy and minimise the toxicity of the procedure.
- gene therapy
- liver disease
- viral hepatitis
- liver malignancies
- ITR, inverted terminal repeat
- AAV, adeno associated virus
- HSV, herpes simplex virus
- IFN-α, interferon α
- IL, interleukin
- AFP, α fetoprotein
- GM-CSF, granulocyte macrophage-colony stimulating factor
- AdCE1, adenovirus containing the core and E1 sequences from hepatitis C virus
- AdIL-12, adenovirus containing genes of IL-12
- WHV, woodchuck hepatitis virus
- HCC, hepatocellular carcinoma
- HSV-tk, HSV-thymidine kinase
Statistics from Altmetric.com
- ITR, inverted terminal repeat
- AAV, adeno associated virus
- HSV, herpes simplex virus
- IFN-α, interferon α
- IL, interleukin
- AFP, α fetoprotein
- GM-CSF, granulocyte macrophage-colony stimulating factor
- AdCE1, adenovirus containing the core and E1 sequences from hepatitis C virus
- AdIL-12, adenovirus containing genes of IL-12
- WHV, woodchuck hepatitis virus
- HCC, hepatocellular carcinoma
- HSV-tk, HSV-thymidine kinase